Ledger.Open graph →
SEC Form D · filed March 23, 2021

Abfero Pharmaceuticals, Inc

Offering
$1.0M
Sold
$500K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LEXINGTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Michael X. Penington · Boston, MADirectorThomas X. Neenan · Boston, MAExec · DirectorSteven X. Burke · Boston, MAExec · DirectorMichael X. Penington · Boston, MADirectorThomas X. Neenan · Boston, MAExec · DirectorSteven X. Burke · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗